Voya Investment Management LLC Biotechnology

Voya Investment Management LLC

$71.9 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ABSI Absci Corp	$267M	$55,000 0.0% of portfolio	22,208	Q1 2025 Reduced 13.06%
OCGN Ocugen, Inc.	$217M	$55,000 0.0% of portfolio	78,604	Q1 2025 Reduced 3.79%
PGEN Precigen, Inc.	$379M	$54,000 0.0% of portfolio	36,771	Q1 2025 Added 142.91%
TERN Terns Pharmaceuticals, Inc.	$213M	$54,000 0.0% of portfolio	19,796	Q1 2025 Reduced 3.34%
FULC Fulcrum Therapeutics, Inc.	$413M	$53,000 0.0% of portfolio	18,548	Q1 2025 Reduced 6.74%
GLUE Monte Rosa Therapeutics, Inc.	$276M	$53,000 0.0% of portfolio	11,613	Q1 2025 Reduced 4.54%
ANNX Annexon, Inc.	$111M	$52,000 0.0% of portfolio	27,455	Q1 2025 Reduced 3.97%
ALLO Allogene Therapeutics, Inc.	$178M	$50,000 0.0% of portfolio	34,597	Q1 2025 Reduced 8.49%
CRDF Cardiff Oncology, Inc.	$195M	$50,000 0.0% of portfolio	16,104	Q1 2025 Added 22.71%
FDMT 4 D Molecular Therapeutics, Inc.	$141M	$46,000 0.0% of portfolio	14,500	Q1 2025 Reduced 6.49%
YMAB Y M Abs Therapeutics, Inc.	$189M	$45,000 0.0% of portfolio	10,211	Q1 2025 Reduced 12.69%
OLMA Olema Pharmaceuticals, Inc.	$182M	$44,000 0.0% of portfolio	11,779	Q1 2025 Reduced 5.94%
VYGR Voyager Therapeutics, Inc.	$124M	$44,000 0.0% of portfolio	13,102	Q1 2025 Reduced 12.58%
HUMA Humacyte, Inc.	$249M	$42,000 0.0% of portfolio	24,914	Q1 2025 Reduced 5.24%
RGLS Regulus Therapeutics Inc.	$119M	$37,000 0.0% of portfolio	21,368	Q1 2025 Reduced 7.39%
PBYI Puma Biotechnology, Inc.	$153M	$36,000 0.0% of portfolio	12,366	Q1 2025 Reduced 16.32%
QSI Quantum Si Inc	$217M	$35,000 0.0% of portfolio	29,552	Q1 2025 Reduced 4.25%
ADCT Adc Therapeutics Sa	$241M	$31,000 0.0% of portfolio	22,273	Q1 2025 Reduced 6.36%
ALEC Alector, Inc.	$138M	$30,000 0.0% of portfolio	24,621	Q1 2025 Reduced 4.44%
ATOS Atossa Therapeutics, Inc.	$110M	$28,000 0.0% of portfolio	41,846	Q1 2025 Reduced 5.39%
EDIT Editas Medicine, Inc.	$188M	$28,000 0.0% of portfolio	24,546	Q1 2025 Reduced 6.76%
NKTX Nkarta, Inc.	$97.3M	$28,000 0.0% of portfolio	15,606	Q1 2025 Reduced 5.4%
CCCC C4 Therapeutics, Inc.	$107M	$27,000 0.0% of portfolio	17,322	Q1 2025 Reduced 5.23%
LYEL Lyell Immunopharma, Inc.	$2.36B	$27,000 0.0% of portfolio	50,329	Q1 2025 Reduced 4.92%
ZNTL Zentalis Pharmaceuticals, Inc.	$82.1M	$27,000 0.0% of portfolio	17,282	Q1 2025 Reduced 69.69%
CHRS Coherus Bio Sciences, Inc.	$70M	$26,000 0.0% of portfolio	33,119	Q1 2025 Reduced 5.2%
PROK Prokidney Corp Ord Shs Cl A(Cy	$41.2M	$26,000 0.0% of portfolio	30,125	Q1 2025 Reduced 5.06%
LRMR Larimar Therapeutics, Inc.	$144M	$25,000 0.0% of portfolio	12,092	Q1 2025 Reduced 5.03%
FATE Fate Therapeutics Inc	$112M	$23,000 0.0% of portfolio	29,676	Q1 2025 Reduced 5.06%
STRO Sutro Biopharma, Inc.	$40.2M	$23,000 0.0% of portfolio	36,487	Q1 2025 Added 13.5%
CRBU Caribou Biosciences, Inc.	$111M	$22,000 0.0% of portfolio	25,165	Q1 2025 Reduced 5.32%
PLRX Pliant Therapeutics, Inc.	$69.1M	$22,000 0.0% of portfolio	16,319	Q1 2025 Reduced 53.14%
VERU Veru Inc.	$48.9M	$21,000 0.0% of portfolio	43,156	Q1 2025 Added 1.3%
VTYX Ventyx Biosciences, Inc.	$185M	$20,000 0.0% of portfolio	18,078	Q1 2025 Reduced 5.88%
APLT Applied Therapeutics Inc.	$22.1M	$19,000 0.0% of portfolio	39,060	Q1 2025 Added 34.16%
TNGX Tango Therapeutics, Inc.	$604M	$19,000 0.0% of portfolio	14,398	Q1 2025 Reduced 4.96%
CABA Cabaletta Bio, Inc.	$49.3M	$18,000 0.0% of portfolio	12,981	Q1 2025 Reduced 8.6%
BDTX Black Diamond Therapeutics, Inc.	$118M	$17,000 0.0% of portfolio	11,518	Q1 2025 Reduced 6.56%
SAVA Cassava Sciences Inc	$84.2M	$17,000 0.0% of portfolio	11,556	Q1 2025 Reduced 5.7%
LCTX Lineage Cell Therapeutics, Inc.	$168M	$17,000 0.0% of portfolio	38,835	Q4 2024 Reduced 31.61%
PYXS Pyxis Oncology, Inc.	$41.8M	$15,000 0.0% of portfolio	15,897	Q4 2024 Reduced 7.57%
XFOR X4 Pharmaceuticals, Inc	$99.5M	$14,000 0.0% of portfolio	59,322	Q1 2025 Added 1.06%
LXRX Lexicon Pharmaceuticals, Inc.	$255M	$6,000 0.0% of portfolio	13,922	Q1 2025 Reduced 63.76%
MRSN Mersana Therapeutics, Inc.	$35M	$3,000 0.0% of portfolio	10,123	Q1 2025 Reduced 72.03%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	65,723	Q1 2025 Reduced 2.31%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.